Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 13/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | CASR | P41180 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11048686 | 0.91 | CNR1 (0.70) | CNR1SLC6A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11052587 | 0.84 | EPHX1 (0.74) | CNR1SLC6A3SMN1; SMN2EPHX1 | |
| SCHEMBL15741900 | 0.83 | FOLH1 (0.65) | CNR1SLC6A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL16872738 | 0.82 | CNR1 (0.49) | CNR1SLC6A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4094826 | 0.82 | CNR1 (0.49) | CNR1SLC6A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11051084 | 0.82 | CNR1 (0.83) | CNR1NPC1RAB9ASMN1; SMN2CASR | |
| SCHEMBL14424476 | 0.82 | EPHX1 (0.71) | CNR1SLC6A3SMN1; SMN2EPHX1 | |
| SCHEMBL27929217 | 0.81 | CNR1 (0.66) | CNR1SLC6A3NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL10939812 | 0.81 | CNR1 (0.70) | CNR1NPC1RAB9ASMN1; SMN2CASR | |
| SCHEMBL8243576 | 0.80 | HDAC1 (0.70) | CNR1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080272062-A1 | BROAD SPECTRUM ANTIMICROBIAL PURIFICATION DEVICES AND METHODS FOR PURIFYING FLUIDS | WATER VISIONS INTERNATIONAL, INC. (US) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080272062-A1 | BROAD SPECTRUM ANTIMICROBIAL PURIFICATION DEVICES AND METHODS FOR PURIFYING FLUIDS | AMPD1, CLPP, SAMHD1 | CNR1 4349/4885SLC6A3 3483/4885NPC1 3672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.